Top Institutions in Ophthalmology - Retinal Diseases
Institutions leading in this area have extensive clinical trial experience with complement inhibitors for GA, strong retinal disease research programs, and active participation in multicenter studies like GATHER2. Their expertise includes translational research, clinical trial design, and retinal imaging technologies.
-
#1
Bascom Palmer Eye Institute
Miami, FL
Bascom Palmer is consistently ranked as a top ophthalmology center with a robust retinal research program and leadership in clinical trials for age-related macular degeneration and geographic atrophy treatments.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
Known for its cutting-edge research in retinal diseases and active participation in pivotal clinical trials for novel GA therapies, including complement inhibition.
-
#3
Johns Hopkins Wilmer Eye Institute
Baltimore, MD
Wilmer Eye Institute has a strong focus on retinal degenerative diseases and has contributed significantly to clinical trials and long-term studies on GA and complement inhibition therapies.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF has a comprehensive retinal disease program with significant contributions to clinical trials investigating complement inhibitors for GA and early intervention strategies.
-
#5
Mayo Clinic
Rochester, MN
Mayo Clinic combines clinical excellence with research in retinal diseases, including involvement in studies on complement inhibition and long-term outcomes in geographic atrophy.
